Robert Coffin
Fundador en REPLIMUNE GROUP, INC. .
Fortuna: 11 M $ al 30/04/2024
Cargos activos de Robert Coffin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Director/Miembro de la Junta | 01/03/2015 | - |
| Director Técnico/Científico/I+D | - | - | |
| Fundador | 01/03/2015 | - | |
| Director Ejecutivo | 01/03/2015 | 09/01/2020 | |
| Presidente | 01/03/2015 | 01/04/2024 |
Historial de carrera de Robert Coffin
Antiguos cargos conocidos de Robert Coffin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Director/Miembro de la Junta | 01/01/1999 | 24/01/2013 |
| Director Técnico/Científico/I+D | 01/01/1999 | 24/01/2013 | |
| Fundador | 15/10/2009 | 24/01/2013 | |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2013 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Director/Miembro de la Junta | 01/01/1999 | 04/03/2011 |
| Director Técnico/Científico/I+D | 01/01/1999 | 04/03/2011 | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Director/Miembro de la Junta | 01/01/1999 | - |
| Director Técnico/Científico/I+D | 01/01/1999 | - | |
| Fundador | 01/01/1999 | - |
Formación de Robert Coffin.
| Imperial College London | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Reino Unido | 3 |
Operativa
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
Sectorial
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Coffin
- Experiencia
